BrainStorm Therapeutics Revenue
Biotechnology Research • 
San Diego, California, United States • 1-10 Employees
BrainStorm Therapeutics revenue & valuation
| Annual revenue | $684,440 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,200,000 |
| Total funding | No funding |
Key Contacts at BrainStorm Therapeutics
Maya Gosztyla
Co-Founder And Chief Scientific Officer
Julie Clifford
Acting Director Of Human Resources Consultant
Company overview
| Headquarters | 5370 Toscana Way, H208, San Diego, California 92122, US |
| Website | |
| NAICS | 541714 |
| Keywords | Stem Cells, Systems Biology, Electrophysiology, Parkinson'S Disease, Dementia, Genomics, Epilepsy, Transcriptomics, Neurodegeneration, Alzheimer'S Disease, Computational Biology, Functional Genomics, Organoids, Network Biology, Ipsc, Synapse, Astrocytes |
| Founded | 2023 |
| Employees | 1-10 |
BrainStorm Therapeutics Email Formats
BrainStorm Therapeutics uses 2 email formats. The most common is {first initial} (e.g., j@brainstormtherapeutics.org), used 75% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@brainstormtherapeutics.org | 75% |
{first initial}.{last name} | j.doe@brainstormtherapeutics.org | 25% |
About BrainStorm Therapeutics
At BrainStorm Therapeutics, we are united by a mission to transform the future of brain health. We are building an NSF-funded, NVIDIA award-winning human brain organoid platform that integrates cutting-edge biology with advanced AI to discover and develop disease-modifying therapies for complex brain disorders. Using patient-derived brain organoids engineered with disease-driving mutations, we apply high-throughput screening and AI-driven foundation models to map gene networks, identify validated targets, and advance drug candidates that can reverse disease progression. Our founding team has already demonstrated the power of this approach, advancing a therapeutic candidate for Rett syndrome from organoid screening into a Phase 2 clinical trial. We are now advancing programs in rare genetic neurodevelopmental disorders and conditions involving dopamine neuron dysfunction, including Parkinson’s disease, schizophrenia, and addiction. With its scalability and precision, our platform has the potential to unlock therapies across a broad spectrum of brain disorders.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
BrainStorm Therapeutics has 5 employees across 2 departments.
Departments
Number of employees
Funding Data
BrainStorm Therapeutics has never raised funding before.
BrainStorm Therapeutics Tech Stack
Discover the technologies and tools that power BrainStorm Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
CDN
JavaScript graphics
JavaScript libraries
Ecommerce
Miscellaneous
Security
Miscellaneous
Page builders
JavaScript libraries
Miscellaneous
CDN
Malaysia
Italy
Frequently asked questions
4.8
40,000 users
